Philippe Lawton

Prof. Philippe Lawton

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2017 in Lipids
Verified
Journal Article
Open access
PDF file
HMHana Bouazizi‐Ben Messaoud
Hana Bouazizi‐Ben Messaoud
MGMarion Guichard
Marion Guichard
PLPhilippe Lawton
Philippe Lawton
IDIsabelle Delton
Isabelle Delton
SASamira Azzouz‐Maache
Samira Azzouz‐Maache
Leishmania sp., are trypanosomatid parasites that are phagocytized by human and animal macrophages. Transformation from the vector promastigote stage to the intracellular amastigote host cell stage is mandatory, since development in the host depends on the internalization of the parasite. We identified and analyzed the lipids involved in the promastigote to amastigote transformation process in the Leishmania donovani complex. Four lipid classes, phospholipids, free fatty acids, triglycerides and sterols were studied. The derivatization method of Bligh and Dyer was used to establish the fatty acid composition in each stage of the parasite. To stay within the context of Leishmania infection, we used amastigotes extracted from macrophages after experimental in vitro infection. The purification process was checked by electronic microscopy, the absence of major contamination by host‐cell debris and a correct purification yield validated our experimental model. Our results show that free fatty acids and cholesterol increased, whereas triglycerides and ergosterol decreased during the transition between promastigotes to amastigotes. With respect to phospholipid classes, we found increased proportion of sphingomyelin and phosphatidylserine and lowered proportion of phosphatidylinositol and lysophosphatidylethanolamine. Regarding fatty acid composition, a significant increase of n‐7 fatty acids was observed in amastigotes. Overall, the total n‐6 fatty acids were decreased in PL. Several of the changes were also observed in TG and free fatty acids. Particularly, n‐7 fatty acids and 20:4n‐6 were highly increased, whereas n‐9 fatty acid and n‐6 precursors decreased.

1 August 2001 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
MSMarianne Stettler
Marianne Stettler
MSMar Siles-Lucas
Mar Siles-Lucas
ESElisabeth Sarciron
Elisabeth Sarciron
PLPhilippe Lawton
Philippe Lawton
BGBruno Gottstein
Bruno Gottstein
AHAndrew Hemphill
Andrew Hemphill
Alveolar echinococcosis (AE) is caused by the metacestode stage of the fox tapeworm Echinococcus multilocularis . The disease affects the human liver and occasionally other organs and is fatal if treatment is unsuccessful. The present chemotherapy of AE is based on the administration of benzimidazole carbamate derivatives, such as mebendazole and albendazole. Albendazole treatment has been found to be ineffective in some cases, parasitostatic rather than parasiticidal, and the recurrence rate is rather high. Therefore, chemotherapy usually involves the lifelong uptake of massive doses of albendazole and new treatment options are urgently needed. In order to avoid costly and time-consuming animal experimentation, a first step in searching for novel parasiticidal compounds could be the in vitro drug screening of novel compounds by employing metacestode cultivation. However, presently used techniques (e.g., transmission electron microscopy) for determination of parasite viability involve costly equipment and time-consuming preparation of rather large amounts of parasite material. We therefore searched for a parasite marker which can be easily traced and the presence or absence of which is indicative of parasite viability. In this study we show that the increase of E. multilocularis alkaline phosphatase activity in culture supernatants during in vitro drug treatment with albendazole derivatives correlates with the progressive degeneration and destruction of the metacestode tissue. The inexpensive and rapid assay presented here will serve as an ideal tool for performing first-round in vitro tests on the efficacy of a large number of antiparasitic compounds.

7 May 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EMErica S. Martins-Duarte
Erica S. Martins-Duarte
Faustine DubarFaustine Dubar
Faustine Dubar
PLPhilippe Lawton
Philippe Lawton
CSCristiane França da Silva
Cristiane França da Silva
MSMaria de Nazaré C. Soeiro
Maria de Nazaré C. Soeiro
RVRossiane C Vommaro
Rossiane C Vommaro
Toxoplasmosis, caused by the protozoan Toxoplasma gondii, is a worldwide disease whose clinical manifestations include encephalitis and congenital malformations in newborns. Previously, we described the synthesis of new ethyl-ester derivatives of the antibiotic ciprofloxacin with ~40-fold increased activity against T. gondii in vitro, compared with the original compound. Cipro derivatives are expected to target the parasite’s DNA gyrase complex in the apicoplast. The activity of these compounds in vivo, as well as their mode of action, remained thus far uncharacterized. Here, we examined the activity of the Cipro derivatives in vivo, in a model of acute murine toxoplasmosis. In addition, we investigated the cellular effects T. gondii tachyzoites in vitro, by immunofluorescence and transmission electron microscopy (TEM). When compared with Cipro treatment, 7-day treatments with Cipro derivatives increased mouse survival significantly, with 13–25% of mice surviving for up to 60 days post-infection (vs. complete lethality 10 days post-infection, with Cipro treatment). Light microscopy examination early (6 and 24h) post-infection revealed that 6-h treatments with Cipro derivatives inhibited the initial event of parasite cell division inside host cells, in an irreversible manner. By TEM and immunofluorescence, the main cellular effects observed after treatment with Cipro derivatives and Cipro were cell scission inhibition - with the appearance of ‘tethered’ parasites – malformation of the inner membrane complex, and apicoplast enlargement and missegregation. Interestingly, tethered daughter cells resulting from Cipro derivatives, and also Cipro, treatment did not show MORN1 cap or centrocone localization. The biological activity of Cipro derivatives against C. parvum, an apicomplexan species that lacks the apicoplast, is, approximately, 50 fold lower than that in T. gondii tachyzoites, supporting that these compounds targets the apicoplast. Our results show that Cipro derivatives improved the survival of mice acutely infected with T. gondii and inhibited parasite replication early in the first cycle of infection in vitro, highlighting their therapeutic potential for the treatment of toxoplasmosis.

1 February 1997 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
ESElisabeth M. Sarciron
Elisabeth M. Sarciron
SBSolange Bresson‐Hadni
Solange Bresson‐Hadni
MMMariette Mercier
Mariette Mercier
PLPhilippe Lawton
Philippe Lawton
CDChristelle Duranton
Christelle Duranton
DVDominique A. Vuitton
Dominique A. Vuitton

Verified
Journal Article
Open access
PDF file
MLMarine Leroux
Marine Leroux
CLCéline Luquain-Costaz
Céline Luquain-Costaz
PLPhilippe Lawton
Philippe Lawton
SASamira Azzouz-Maache
Samira Azzouz-Maache
IDIsabelle Delton
Isabelle Delton
Fatty acids have received growing interest in Leishmania biology with the characterization of the enzymes allowing the complete fatty acid synthesis of this trypanosomatid parasite. This review presents a comparative analysis of the fatty acid profiles of the major classes of lipids and phospholipids in different species of Leishmania with cutaneous or visceral tropism. Specificities relating to the parasite forms, resistance to antileishmanial drugs, and host/parasite interactions are described as well as comparisons with other trypanosomatids. Emphasis is placed on polyunsaturated fatty acids and their metabolic and functional specificities, in particular, their conversion into oxygenated metabolites that are inflammatory mediators able to modulate metacyclogenesis and parasite infectivity. The impact of lipid status on the development of leishmaniasis and the potential of fatty acids as therapeutic targets or candidates for nutritional interventions are discussed.

30 June 2008 in Phytochemistry
Verified
Journal Article
Closed access
KOKarima Oughlissi-Dehak
Karima Oughlissi-Dehak
PLPhilippe Lawton
Philippe Lawton
SMSerge Michalet
Serge Michalet
CBChristine Bayet
Christine Bayet
NDNicole Darbour
Nicole Darbour
DGDavid Guilet
David Guilet